Additionally, exploring the role of other regulatory microRNAs in modulating ABC transporter expression could unveil novel targets for combination therapies, ultimately leading to more effective treatment regimens for ovarian cancer patients. The gene discussed is ABCG2; the disease is ovarian cancer.